[Research Report] The radiopharmaceutical theranostics market size is expected to grow from US$ 1,814.58 million in 2022 to US$ 3,441.97 million by 2028; it is estimated to record a CAGR of 11.3% from 2022 to 2028.
The radiopharmaceutical theranostics market is segmented on the basis of product type, radioisotope, source, application, indication, end user, and geography. The report offers insights and in-depth analysis of the market, emphasizing parameters such as dynamics, trends, and opportunities prevailing in the radiopharmaceutical theranostics market. It also provides the competitive landscape analysis of leading market players in global radiopharmaceutical theranostics market.
Market Insights
Rising Application in Treatment of Cardiovascular Disorders Drives Global Radiopharmaceutical Theranostics Market Growth
Cardiovascular diseases (CVDs) are among the most prevalent chronic diseases of the 21st century, with a high mortality rate. Due to their sedentary lifestyle, CVDs are the leading cause of mortality and morbidity in developed countries. In addition, obesity and diabetes, and related diseases are associated with cardiovascular disease and are becoming comorbid. In addition, a complication such as coronary artery obstruction is one of the number one causes of death in adults, resulting in thrombus plaque in the intima of the arterial wall, mainly in the carotid artery. According to data from the National Center for Biotechnology, around 17.7 million people died worldwide in 2015 due to cardiovascular diseases. In this regard, it is estimated that mortality from cardiovascular disease could increase to 22 million by 2030. Therapeutic applications in cardiovascular diseases include nanomedicine in angina pectoris, myocarditis, myocardial infarction, pericardial disease, thrombosis, atherosclerosis, hyperlipidemia, hypertension, pulmonary arterial hypertension, and stroke. Theranostics nanomedicines can prolong systemic circulation, evade host defense systems, and deliver theranostics agents to the target site for imaging and therapy at the cellular and molecular levels.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiopharmaceutical Theranostics Market: Strategic Insights
Market Size Value in US$ 1,814.58 million in 2022 Market Size Value by US$ 3,441.97 million by 2028 Growth rate CAGR of 11.3% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiopharmaceutical Theranostics Market: Strategic Insights
| Market Size Value in | US$ 1,814.58 million in 2022 |
| Market Size Value by | US$ 3,441.97 million by 2028 |
| Growth rate | CAGR of 11.3% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
As per the 2022 report by the Centers for Disease Control and Prevention (CDC), heart disease is a leading cause of death among men and women in the US. Heart disease was a cause of ~697,000 deaths, i.e., 1 in 5 deaths, in the US in 2020. A National Institute of Health (NIH) report states that theranostics nanoparticles have gained significant attention in the medical field, as the techniques help overcome complexities and pathophysiological complications associated with CVDs. Cardiovascular imaging of atherosclerosis patients provides pathophysiological evidence that can help treat CVDs. Further, theranostics nanoparticles can be combined with a range of imaging techniques, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT). Various clinical research studies have been conducted in clinical laboratories so far. A three-in-one therapeutic complex has been constructed, by combining a polymeric photoacoustic probe with nanoparticles-PLCDP@PMH. Clinical in-vivo evaluations reveal that the PLCDP@PMH provides lucrative advantages for the theranostics approach to early-stage atherosclerosis detection in patients.
Product Type-Based Insights
Based on product type, the radiopharmaceutical theranostics market is segmented into positron emission tomography (PET) tracers, beta emitters, and alpha emitters. In 2022, the positron emission tomography (PET) tracers segment held the largest share of the market of global radiopharmaceutical theranostics market, and it is anticipated to register the highest CAGR during the forecast period.
Radiopharmaceutical Theranostics Market, by Product Type – 2022–2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Radioisotope-Based Insights
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on radioisotope, the radiopharmaceutical theranostics market is divided into Lutetium (Lu) 177, Gallium-68, Iodine-131, Iodine-123, Technetium-99, Yttrium-90 (Y-90), Copper (Cu) 64, 18F, Copper (Cu) 67, and others. In 2022, the Lutetium (Lu) 177 segment held the largest market share of the global radiopharmaceutical theranostics market and is anticipated to register the highest CAGR during the forecast period.
Source-Based Insights
Based on source, the radiopharmaceutical theranostics market is bifurcated into cyclotrons and nuclear reactors. The cyclotrons segment held a larger share of the market in 2022, and it is expected to record at a higher CAGR during the forecast period.
Application-Based Insights
Based on application, the radiopharmaceutical theranostics market is bifurcated into targeted therapeutic (Rx) and companion diagnostic (CDx). In 2022, the targeted therapeutic (Rx) segment held a larger share of the market, and it is anticipated to register a higher CAGR during the forecast period.
Indication-Based Insights
Based on indication, the radiopharmaceutical theranostics market is segmented into oncology, neurology, cardiology, and others. The oncology segment held the largest share of the market in 2022, and it is anticipated to register the highest CAGR during the forecast period.
End User-Based Insights
Based on end user, the radiopharmaceutical theranostics market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and others. The hospitals segment held the largest market share in 2022. However, the academic and research institutes segment is anticipated to register the highest CAGR during the forecast period. Hospitals employ technologically advanced systems to treat cardiac aneurysms, neurology aneurysms, oncology tumors, and other similar conditions. The rising prevalence of various diseases and an increasing number of hospitals contribute to the growth of the market for hospitals segment.
The radiopharmaceutical theranostics market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio and meet growing demands. Inorganic growth strategies witnessed in the market are partnerships and collaborations. These growth strategies have allowed the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help them strengthen their customer base.
- In October 2022, Telix received Health Canada approval for its Illuccix, a kit for the preparation of gallium (68Ga) gozetotide injection. The product can be used in staging and re-staging intermediate and high-risk prostate cancer and localizing tumor tissue in recurrent prostate cancer. Illuccix was the first PSMA PET imaging agent that was granted regulatory approval in Canada. Health Canada was the third regulatory body worldwide to approve Illuccix, which is commercially available in Australia and the US.
- In December 2021, GE Healthcare and Minerva Imaging entered in a strategic partnership to accelerate the commercial launch of targeted radionuclide therapies (theranostics). Radionuclide therapy is a form of precision medicine where a radioactive substance is administered through the bloodstream to target cancer cells and irradiate them specifically. This helps reduce potential side effects compared to traditional cancer therapies.
Company Profiles - Radiopharmaceutical Theranostics Market
- Bayer AG
- GE HealthCare Technologies Inc
- Curium
- Lantheus Medical Imaging, Inc.
- Telix Pharmaceuticals Ltd.
- Cardinal Health Inc
- Advanced Accelerator Applications S.A.
- Jubilant Radiopharma
- Theragnostics
- NuView Life Sciences
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Radioisotope, Source, Application, Indication, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. Nuclear medicine imaging generally utilizes radioactive isotopes attached to specific molecules to examine biological processes, such as disease pathophysiology. Every radiopharmaceutical is designed to travel to a specific location in the body, and as soon as it reaches the site, it releases radioactive substances that kill the tumor cells. Radiopharmaceuticals can target various malignancies such as prostate cancer, heart disease, thyroid cancer, and others. These drugs can also be used as both therapies and diagnostics, known as 'theranostics’. In theranostics, radiopharmaceuticals are used for therapeutic and diagnostic purposes by targeting one specific tumor receptor.
Key factors that are driving the growth of this market are rising incidence of cancer and the growing application in the treatment of cardiovascular disorders are expected to boost the market growth for the radiopharmaceutical theranostics over the years.
The CAGR value of the biopharmaceuticals market during the forecasted period of 2022-2028 is 11.3%.
The positron emission tomography (PET) tracers segment held the largest share of the market in the global radiopharmaceutical theranostics market and held the largest market share of 44.76% in 2022.
The Lutetium (Lu) 177 segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 24.34% in 2022.
The cyclotrons segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 60.42% in 2022.
Answer: - The targeted therapeutic [Rx] segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 63.28% in 2022.
The oncology segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 62.18% in 2022.
The hospitals segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 36.28% in 2022.
The radiopharmaceutical theranostics market majorly consists of the players such Bayer AG, GE HealthCare Technologies Inc, Curium, Lantheus Medical Imaging, Inc.; Telix Pharmaceuticals Ltd.; Cardinal Health Inc, Advanced Accelerator Applications S.A.; Jubilant Radiopharma, Theragnostics, and NuView Life Sciences amongst others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Radiopharmaceutical Theranostics Market – by Product Type
1.3.2 Global Radiopharmaceutical Theranostics Market – by Radioisotope
1.3.3 Global Radiopharmaceutical Theranostics Market – by Source
1.3.4 Global Radiopharmaceutical Theranostics Market – by Application
1.3.5 Global Radiopharmaceutical Theranostics Market – by Indication
1.3.6 Global Radiopharmaceutical Theranostics Market – by End User
1.3.7 Global Radiopharmaceutical Theranostics Market – by Geography
2. Radiopharmaceutical Theranostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Radiopharmaceutical Theranostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Radiopharmaceutical Theranostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer
5.1.2 Rising Application in Treatment of Cardiovascular Disorders
5.2 Market Restraints
5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
5.3 Market Opportunities
5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
5.4 Future Trends
5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
5.5 Impact Analysis
6. Radiopharmaceutical Theranostics Market – Global Analysis
6.1 Global Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis
6.2 Global Radiopharmaceutical Theranostics Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1 GE HealthCare Technologies Inc
6.3.2 Curium
7. Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type
7.1 Overview
7.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
7.2.1 Positron Emission Tomography (PET) Tracers
7.2.1.1 Overview
7.2.1.2 Positron Emission Tomography (PET) Tracers: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.2.2 Beta Emitters
7.2.2.1 Overview
7.2.2.2 Beta Emitters: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.2.3 Alpha Emitters
7.2.3.1 Overview
7.2.3.2 Alpha Emitters: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Radiopharmaceutical Theranostics Market Analysis – by Radioisotope
8.1 Overview
8.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)
8.2.1 Technetium-99
8.2.1.1 Overview
8.2.1.2 Technetium-99: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.2 Gallium-68
8.2.2.1 Overview
8.2.2.2 Gallium-68: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.3 Iodine-131
8.2.3.1 Overview
8.2.3.2 Iodine-131: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.4 Iodine-123
8.2.4.1 Overview
8.2.4.2 Iodine-123: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.5 Fluorine-18 (18F)
8.2.5.1 Overview
8.2.5.2 Fluorine-18 (18F): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.6 Yttrium 90 (Y-90)
8.2.6.1 Overview
8.2.6.2 Yttrium 90 (Y-90): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.7 Lutetium (LU) 177
8.2.7.1 Overview
8.2.7.2 Lutetium (LU) 177: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.8 Copper (CU) 67
8.2.8.1 Overview
8.2.8.2 Copper (CU) 67: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.9 Copper (CU) 64
8.2.9.1 Overview
8.2.9.2 Copper (CU) 64: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2.10 Others
8.2.10.1 Overview
8.2.10.2 Others: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Radiopharmaceutical Theranostics Market Analysis – by Source
9.1 Overview
9.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)
9.2.1 Nuclear Reactors
9.2.1.1 Overview
9.2.1.2 Nuclear Reactors: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.2 Cyclotrons
9.2.2.1 Overview
9.2.2.2 Cyclotrons: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Global Radiopharmaceutical Theranostics Market Analysis – by Application
10.1 Overview
10.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)
10.2.1 Targeted Therapeutic (Rx)
10.2.1.1 Overview
10.2.1.2 Targeted Therapeutics (Rx): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.2 Companion Diagnostic (CDx)
10.2.2.1 Overview
10.2.2.2 Companion Diagnostics (CDx): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11. Global Radiopharmaceutical Theranostics Market Analysis – by Indication
11.1 Overview
11.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)
11.2.1 Oncology
11.2.1.1 Overview
11.2.1.2 Oncology: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.2.2 Neurology
11.2.2.1 Overview
11.2.2.2 Neurology: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.2.3 Cardiology
11.2.3.1 Overview
11.2.3.2 Cardiology: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.2.4 Others
11.2.4.1 Overview
11.2.4.2 Others: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12. Global Radiopharmaceutical Theranostics Market Analysis – by End User
12.1 Overview
12.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)
12.2.1 Hospitals
12.2.1.1 Overview
12.2.1.2 Hospitals: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12.2.2 Diagnostic Imaging Centers
12.2.2.1 Overview
12.2.2.2 Diagnostic Imaging Centers: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Academic & Research Institutes
12.2.3.1 Overview
12.2.3.2 Academic & Research Institutes: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
12.2.4 Others
12.2.4.1 Overview
12.2.4.2 Others: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13. Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – Geographic Analysis
13.1 North America: Radiopharmaceutical Theranostics Market
13.1.1 Overview
13.1.2 North America: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.3 North America: Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.1.4 North America: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.1.5 North America: Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.1.6 North America: Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.1.7 North America: Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.1.8 North America: Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.1.8.1 United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.8.1.1 Overview
13.1.8.1.2 United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.8.1.3 United States Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.1.8.1.4 United States Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.1.8.1.5 United States Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.1.8.1.6 United States Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.1.8.1.7 United States Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.1.8.1.8 United States Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.1.8.2 Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.8.2.1 Overview
13.1.8.2.2 Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.8.2.3 Canada Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.1.8.2.4 Canada Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.1.8.2.5 Canada Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.1.8.2.6 Canada Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.1.8.2.7 Canada Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.1.8.2.8 Canada Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.1.8.3 Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.8.3.1 Overview
13.1.8.3.2 Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.8.3.3 Mexico Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.1.8.3.4 Mexico Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.1.8.3.5 Mexico Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.1.8.3.6 Mexico Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.1.8.3.7 Mexico Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.1.8.3.8 Mexico Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.2 Europe: Radiopharmaceutical Theranostics Market
13.2.1 Overview
13.2.2 Europe: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.3 Europe: Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.2.4 Europe: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.2.5 Europe: Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.2.6 Europe: Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.2.7 Europe: Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.2.8 Europe: Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.2.9 Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.2.9.1 Germany: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.1 Overview
13.2.9.1.2 Germany Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.3 Germany Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.2.9.1.4 Germany Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.2.9.1.5 Germany Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.2.9.1.6 Germany Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.2.9.1.7 Germany Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.2.9.1.8 Germany Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.2.9.2 United Kingdom: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.1 Overview
13.2.9.2.2 United Kingdom Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.3 United Kingdom Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)
13.2.9.2.4 United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.2.9.2.5 United Kingdom Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.2.9.2.6 United Kingdom Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.2.9.2.7 United Kingdom Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.2.9.2.8 United Kingdom Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.2.9.3 France: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.1 Overview
13.2.9.3.2 France Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.3 France Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.2.9.3.4 France Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.2.9.3.5 France Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.2.9.3.6 France Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.2.9.3.7 France Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.2.9.3.8 France Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.2.9.4 Italy: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.1 Overview
13.2.9.4.2 Italy Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.3 Italy Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.2.9.4.4 Italy Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.2.9.4.5 Italy Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.2.9.4.6 Italy Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.2.9.4.7 Italy Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.2.9.4.8 Italy Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.2.9.5 Spain: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.1 Overview
13.2.9.5.2 Spain Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.3 Spain Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.2.9.5.4 Spain Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.2.9.5.5 Spain Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.2.9.5.6 Spain Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.2.9.5.7 Spain Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.2.9.5.8 Spain Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.2.9.6 Rest of Europe: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.1 Overview
13.2.9.6.2 Rest of Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.3 Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.2.9.6.4 Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.2.9.6.5 Rest of Europe Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.2.9.6.6 Rest of Europe Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.2.9.6.7 Rest of Europe Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.2.9.6.8 Rest of Europe Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.3 Asia Pacific: Radiopharmaceutical Theranostics Market
13.3.1 Overview
13.3.2 Asia Pacific: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.3 Asia Pacific: Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.3.4 Asia Pacific: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.3.5 Asia Pacific: Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.3.6 Asia Pacific: Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.3.7 Asia Pacific: Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.3.8 Asia Pacific: Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.3.9 Asia Pacific: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.3.9.1 China: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.1 Overview
13.3.9.1.2 China: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.3 China Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.3.9.1.4 China Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.3.9.1.5 China Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.3.9.1.6 China Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.3.9.1.7 China Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.3.9.1.8 China Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.3.9.2 Japan: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.1 Overview
13.3.9.2.2 Japan: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.3 Japan Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.3.9.2.4 Japan Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.3.9.2.5 Japan Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.3.9.2.6 Japan Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.3.9.2.7 Japan Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.3.9.2.8 Japan Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.3.9.3 India: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.3.1 Overview
13.3.9.3.2 India: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.3.3 India Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.3.9.3.4 India Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.3.9.3.5 India Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.3.9.3.6 India Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.3.9.3.7 India Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.3.9.3.8 India Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.3.9.4 South Korea: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.4.1 Overview
13.3.9.4.2 South Korea: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.4.3 South Korea Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.3.9.4.4 South Korea Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.3.9.4.5 South Korea Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.3.9.4.6 South Korea Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.3.9.4.7 South Korea Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.3.9.4.8 South Korea Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.3.9.5 Australia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.5.1 Overview
13.3.9.5.2 Australia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.5.3 Australia Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.3.9.5.4 Australia Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.3.9.5.5 Australia Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.3.9.5.6 Australia Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.3.9.5.7 Australia Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.3.9.5.8 Australia Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.3.9.6 Rest of Asia Pacific: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.6.1 Overview
13.3.9.6.2 Rest of Asia Pacific: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.6.3 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.3.9.6.4 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.3.9.6.5 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.3.9.6.6 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.3.9.6.7 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.3.9.6.8 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.4 Middle East & Africa Radiopharmaceutical Theranostics Market
13.4.1 Overview
13.4.2 Middle East & Africa: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.3 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.4.4 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.4.5 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.4.6 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.4.7 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.4.8 Middle East & Africa: Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.4.9 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.4.9.1 Saudi Arabia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.1.1 Overview
13.4.9.1.2 Saudi Arabia Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.1.3 Saudi Arabia Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.4.9.1.4 Saudi Arabia Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.4.9.1.5 Saudi Arabia Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.4.9.1.6 Saudi Arabia Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.4.9.1.7 Saudi Arabia Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.4.9.1.8 Saudi Arabia Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.4.9.2 South Africa: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.2.1 Overview
13.4.9.2.2 South Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.2.3 South Africa Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)
13.4.9.2.4 South Africa Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.4.9.2.5 South Africa Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.4.9.2.6 South Africa Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.4.9.2.7 South Africa Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.4.9.2.8 South Africa Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.4.9.3 UAE: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.3.1 Overview
13.4.9.3.2 UAE Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.3.3 UAE Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.4.9.3.4 UAE Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.4.9.3.5 UAE Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.4.9.3.6 UAE Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.4.9.3.7 UAE Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.4.9.3.8 UAE Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.4.9.4 Rest of Middle East & Africa: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.4.1 Overview
13.4.9.4.2 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.4.9.4.3 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.4.9.4.4 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.4.9.4.5 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.4.9.4.6 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.4.9.4.7 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.4.9.4.8 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.5 South & Central America Radiopharmaceutical Theranostics Market
13.5.1 Overview
13.5.2 South & Central America: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.5.3 South & Central America: Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.5.4 South & Central America: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.5.5 South & Central America: Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.5.6 South & Central America: Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.5.7 South & Central America: Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.5.8 South & Central America: Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.5.9 South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.5.9.1 Brazil: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.5.9.1.1 Overview
13.5.9.1.2 Brazil Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.5.9.1.3 Brazil Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)
13.5.9.1.4 Brazil Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.5.9.1.5 Brazil Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.5.9.1.6 Brazil Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.5.9.1.7 Brazil Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.5.9.1.8 Brazil Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.5.9.2 Argentina: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.5.9.2.1 Overview
13.5.9.2.2 Argentina Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.5.9.2.3 Argentina Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.5.9.2.4 Argentina Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.5.9.2.5 Argentina Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.5.9.2.6 Argentina Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.5.9.2.7 Argentina Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.5.9.2.8 Argentina Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
13.5.9.3 Rest of South & Central America: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.5.9.3.1 Overview
13.5.9.3.2 Rest of South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.5.9.3.3 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.5.9.3.4 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.5.9.3.5 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)
13.5.9.3.6 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)
13.5.9.3.7 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)
13.5.9.3.8 Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)
14. Impact Of COVID-19 Pandemic on Radiopharmaceutical Theranostics Market
14.1 North America: Impact Assessment of COVID-19 Pandemic
14.2 Europe: Impact Assessment of COVID-19 Pandemic
14.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
14.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
14.5 South & Central America: Impact Assessment of COVID-19 Pandemic
15. Radiopharmaceutical Theranostics Market – Industry Landscape
15.1 Overview
15.2 Growth Strategies in the Radiopharmaceutical Theranostics Market
15.3 Inorganic Growth Strategies
15.3.1 Overview
15.4 Organic Growth Strategies
15.4.1 Overview
16. Company Profiles
16.1 Bayer AG
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 GE HealthCare Technologies Inc
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Curium
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Lantheus Medical Imaging, Inc.
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Telix Pharmaceuticals Ltd.
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Cardinal Health Inc
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Advanced Accelerator Applications S.A.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Jubilant Radiopharma
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Theragnostics
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 NuView Life Sciences
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. United States Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. United States Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 9. United States Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. United States Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. United States Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 12. United States Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 18. Canada Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Europe Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 27. Europe Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 28. Europe Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 29. Europe Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 30. Europe Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Germany Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Germany Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 33. Germany Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 34. Germany Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. Germany Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 36. Germany Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. United Kingdom Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)
Table 38. United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 39. United Kingdom Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 40. United Kingdom Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 41. United Kingdom Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 42. United Kingdom Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 43. France Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 44. France Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 45. France Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 46. France Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 47. France Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 48. France Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Italy Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. Italy Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 51. Italy Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 55. Spain Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Spain Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 57. Spain Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 58. Spain Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 59. Spain Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 60. Spain Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 63. Rest of Europe Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of Europe Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of Europe Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Europe Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 67. Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 69. Asia Pacific Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 70. Asia Pacific Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 71. Asia Pacific Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 72. Asia Pacific Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 73. China Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 74. China Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 75. China Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 76. China Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 77. China Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 78. China Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 79. Japan Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 80. Japan Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 81. Japan Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 82. Japan Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 83. Japan Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 84. Japan Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 85. India Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 86. India Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 87. India Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 88. India Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 89. India Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 90. India Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 91. South Korea Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 92. South Korea Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 93. South Korea Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 94. South Korea Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 95. South Korea Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 96. South Korea Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 97. Australia Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 98. Australia Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 99. Australia Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 100. Australia Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 101. Australia Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 102. Australia Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 103. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 109. Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 110. Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 111. Middle East & Africa Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 112. Middle East & Africa Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 113. Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 114. Middle East & Africa Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 115. Saudi Arabia Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 116. Saudi Arabia Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 117. Saudi Arabia Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 118. Saudi Arabia Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 119. Saudi Arabia Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 120. Saudi Arabia Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 121. South Africa Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)
Table 122. South Africa Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 123. South Africa Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 124. South Africa Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 125. South Africa Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 126. South Africa Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 127. UAE Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 128. UAE Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 129. UAE Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 130. UAE Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 131. UAE Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 132. UAE Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 133. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 136. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 137. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 138. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 139. South & Central America Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 140. South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 141. South & Central America Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 142. South & Central America Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 143. South & Central America Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 144. South & Central America Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 145. Brazil Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)
Table 146. Brazil Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 147. Brazil Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 148. Brazil Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 149. Brazil Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 150. Brazil Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 151. Argentina Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 152. Argentina Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 153. Argentina Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 154. Argentina Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 155. Argentina Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 156. Argentina Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 157. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 158. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 159. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 160. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 161. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 162. Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 163. Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 164. Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 165. Glossary of Terms
LIST OF FIGURES
Figure 1. Radiopharmaceutical Theranostics Market Segmentation
Figure 2. Radiopharmaceutical Theranostics Market, by Region
Figure 3. Global Radiopharmaceutical Theranostics Market Overview
Figure 4. Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Radiopharmaceutical Theranostics Market, by Geography (US$ Million)
Figure 7. Global Radiopharmaceutical Theranostics Market – Leading Country Markets (US$ Million)
Figure 8. Global Radiopharmaceutical Theranostics Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028
Figure 17. Global Radiopharmaceutical Theranostics Market, by Geography – Forecast and Analysis (2021–2028)
Figure 18. Market Positioning of Key Players in Radiopharmaceutical Theranostics Market
Figure 19. Global Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
Figure 20. Positron Emission Tomography (PET) Tracers: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Beta Emitters: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Alpha Emitters: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Global Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
Figure 24. Technetium-99: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Gallium-68: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Iodine-131: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Iodine-123: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Fluorine-18 (18F): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Yttrium 90 (Y-90): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Lutetium (LU) 177: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Copper (CU) 67: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Copper (CU) 64: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Others: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Global Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
Figure 35. Nuclear Reactors: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Cyclotrons: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Global Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
Figure 38. Targeted Therapeutics (Rx): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Companion Diagnostics (CDx): Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Global Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
Figure 41. Oncology: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Neurology: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Cardiology: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Others: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Global Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
Figure 46. Hospitals: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Diagnostic Imaging Centers: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Academic & Research Institutes: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Others: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. North America: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 51. North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. North America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
Figure 53. United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Europe: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 57. Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
Figure 59. Germany Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. United Kingdom Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. France Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Italy Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Spain Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of Europe Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Asia Pacific: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 66. Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 67. China: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. Japan: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. India: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. South Korea: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Australia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Rest of Asia Pacific: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Middle East & Africa: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 74. Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 75. Saudi Arabia Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 76. South Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 77. UAE Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 78. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 79. South & Central America: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 80. South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 81. South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
Figure 82. Brazil Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 83. Argentina Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 84. Rest of South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 85. Impact of COVID-19 Pandemic on North American Country Markets
Figure 86. Impact of COVID-19 Pandemic in European Country Markets
Figure 87. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 88. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 89. Impact of COVID-19 Pandemic on South & Central American Country Markets
Figure 90. Growth Strategies in the Radiopharmaceutical Theranostics Market
The List of Companies - Radiopharmaceutical Theranostics Market
- Bayer AG
- GE HealthCare Technologies Inc
- Curium
- Lantheus Medical Imaging, Inc.
- Telix Pharmaceuticals Ltd.
- Cardinal Health Inc
- Advanced Accelerator Applications S.A.
- Jubilant Radiopharma
- Theragnostics
- NuView Life Sciences
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Radiopharmaceutical Theranostics Market
Mar 2023
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2023
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2023
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2023
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)